FDA Approves New Labeling for VYTORIN to Include Data From SHARP Showing That VYTORIN Effectively Lowered LDL Cholesterol in These Patients, With Fewer Major Vascular Events in Patients Taking VYTORIN ...
Rockville, MD - Simvastatin (Zocor, Merck/Schering-Plough), used at the highest approved dose of 80 mg, is associated with an increased risk of myopathy, including rhabdomyolysis, according to the US ...
Niacin extended-release 500 mg, simvastatin 20 mg; tabs. Simcor combines the HMG-CoA reductase inhibitor, simvastatin, and the nicotinic acid derivative, extended-release niacin (Niaspan, also from ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the ...
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease. Simcor combines prescription ...
WHITEHOUSE STATION and KENILWORTH, N.J., July 23, 2004 — Merck/Schering-Plough Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved VYTORIN TM (ezetimibe/simvastatin ...
Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data ...
Pneumocystis pneumonia in patients with lymphoma: Who should receive prophylaxis? Background: Waldenström macroglobulinemia (WM) is a distinct B-cell lymphoproliferative disorder characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback